TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/17/2025
Back to search
Official data from USPTO
SERCA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
07/23/2025
Trademark type
Combined
Nice classes
5, 35, 40, 42
Filing date
12/20/2021
Registration date
11/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2023
Last transaction
07/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
NO
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a heart design made up of two curved bands, to the left of the term "SERCA" above "PHARMACEUTICALS.
Holders and representatives
Holders
S. A. (pessoa física)
Representatives
Susan Stabe Kutak Rock LLP
Technical classification
Nice Classes
Class 5Class 35Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for treatment of cardiovascular diseases; pharmaceutical preparations for treatment of myocardial infarction; pharmaceutical preparations for prophylactic treatment of cardiovascular diseases; pharmaceutical preparations for prophylactic treatment of myocardial infarction; cardiovascular disease prophylactic preparations for preventing cardiovascular disease; myocardial infarction prophylactic preparations for preventing myocardial infarction
Class 35
Promoting of pharmaceutical products; retail stores services featuring pharmaceutical products; promoting of pharmaceutical products for therapeutic treatment of cardiovascular diseasesproducts for therapeutic treatment of myocardial infarctionproducts for prophylactic treatment of cardiovascular diseases and products for prophylactic treatment of myocardial infarction; retail store services featuring pharmaceutical products for therapeutic treatment of cardiovascular diseasesproducts for therapeutic treatment of myocardial infarctionproducts for prophylactic treatment of cardiovascular diseases and products for prophylactic treatment of myocardial infarction; promoting of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparation; retail store services featuring cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparation
Class 40
Treatment of materials for use in production of pharmaceuticals; production and custom manufacturing of pharmaceuticals; production and custom manufacturing of preparations for treatment of cardiovascular diseasespreparations for treatment of myocardial infarctionpreparations for prophylactic treatment of cardiovascular diseases and preparations for prophylactic treatment of myocardial infarction; production and custom manufacturing of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparations
Class 42
Research and development of pharmaceutical preparations for treatment of cardiovascular diseasespreparations for therapeutic treatment of myocardial infarctionpreparations for prophylactic treatment of cardiovascular diseases and preparations for prophylactic treatment of myocardial infarction; research and development of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparations
Publications
History of USPTO decisions and trademark events.
46 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/17/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/24/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/24/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/24/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/24/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/08/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/04/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/14/2024
FIMP
FINAL DISPOSITION PROCESSED
02/14/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/14/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2023
PUBO
PUBLISHED FOR OPPOSITION
08/29/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/28/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/09/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2023
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
04/13/2023
GPRA
PRIORITY ACTION E-MAILED
04/13/2023
CPRA
PRIORITY ACTION WRITTEN
04/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2023
RFNT
REFUSAL PROCESSED BY IB
12/28/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/07/2022
RFRR
REFUSAL PROCESSED BY MPU
12/07/2022
ATRV
ATTORNEY REVIEW COMPLETED
11/17/2022
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
10/26/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/27/2022
CNRT
NON-FINAL ACTION WRITTEN
09/26/2022
DOCK
ASSIGNED TO EXAMINER
09/26/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/23/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/15/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/10/2022
Continuous trademark protection
Get notified about every new filing that threatens SERCA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.